60 DEGREES PHARMACEUTICALS, INC. (SXTP) Form S-3 — Aug 14, 2026
60 Degrees Pharmaceuticals filed a Form S-3 registering the resale of up to 1,769,593 common shares by selling stockholders from a July 30, 2026 private placement arranged by H.C. Wainwright. The company will receive no proceeds from these sales and is bearing estimated registration expenses of about $135,284. The registered total — 191,571 issued shares plus shares underlying pre-funded warrants ($0.0001 strike), $1.74 Series A/B warrants, and placement agent warrants — equals roughly 50% of the 3,516,988 shares outstanding, a heavy overhang for a stock that last traded at $1.18.
Key figures
- Offering Price
- No fixed price; resale at market ($1.18 last reported sale Aug 13, 2026; $1.16 average high/low used for fee calculation)
- Shares Offered
- 1769593
- Shares Outstanding
- 3516988
- Registration Fee
- 283.48
- Private Placement Date
- 2026-07-30
- Series AWarrant Shares
- 574713
- Series BWarrant Shares
- 574713
- Last Reported Sale Price
- 1.18
- Pre Funded Warrant Shares
- 383142
- Common Warrant Exercise Price
- 1.74
- Placement Agent Warrant Shares
- 45454
- Estimated Registration Expenses
- 135284
- Pre Funded Warrant Exercise Price
- $0.0001
- Placement Agent Warrant Exercise Price
- 2.175
- Registered Shares As Pct Of Outstanding
- 50.3%
Price after filing
Close on the filing date to close N calendar days later (from $1.20). Historical, not a forecast.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.